Castleman's disease is a rare and poorly understood condition involving lymph nodes at various sites, pre-
Introduction
Castleman' s disease is a lymphoproliferative disorder that is uncommon, atypical, and of unknownetiology. It is characterized histologically by angiofollicular lymph node hypertrophy. Two clinical entities have been described: a unicentric presentation with disease confined to a single anatomic lymph node-bearing region and a multicentric presentation in which several sites are affected (1) . Two basic histopathologic types of Castleman's disease have also been distinguished, hyaline vascular and plasma cell, with the latter being less common. However, a clear separation of the two types is not always possible and a mixed type exists. Castleman's disease of the hyaline vascular type is generally asymptomatic and is often discovered incidentally during routine physical examination, chest X-ray, or abdominal ultrasonography (2) (3) (4) Castleman's disease and underwent complete surgical resection of the mass (Table 1) . Histological examination of the surgical specimens provided a diagnosis of hyaline vascular ( Fig. 1C) and plasma cell types of the disease in cases 1 and 2, respectively. Case 1 (hyaline vascular type) was asymptomatic at presentation and her routine laboratory data were mediastinum. B, Coronal Tl-weighted MRimage reveals a homogeneous mass in the middle mediastinum. C, Hematoxylin-eosin staining of a specimen of the resected mass, revealing that the mass was composedof lymphoid follicles containing deposits of hyaline and was transfixed by penetrating capillaries (original xlOO). D, *7Ga scintigraphy was performed with a dual-head large rectangular field-of-view gammacamera (GCA 7200A-DI, GCA90B, Toshiba). Whole body images were obtained 72 hours after injection of lllMBq of *7Ga citrate. Planar imaging on day 3 after 67Ga injection showing absence of abnormal 67Ga uptake.
7Ga Uptake in Castleman's Disease normal. The lesion was discovered incidentally on chest radiographs. This patient remains symptomfree after complete resection of the lesion ( Fig. 1A and B). Case 2 (plasma cell type) was diagnosed with secondary amyloidosis by positive staining of the gastric mucosa with antibodies to serum amyloid protein A. The laboratory findings revealed severe anemia, an increased serum concentration of C-reactive protein, hypoalbuminemia, polyclonal hypergammaglobulinemia, and renal insufficiency. Computed tomography (CT) of the abdomen revealed a clearly bordered mass (5 by 4 cm) with small calcifications in the mesentery. With the exception of renal insufficiency, the laboratory data of the patient had improved by 4 months after surgical resection of the mass. In both patients with unicentric Castleman's disease, 67Ga scintigraphy was performed before surgery but did not reveal abnormal uptake in either case (Fig. ID) . Three patients (cases 3 to 5) met the criteria for multicentric Castleman's disease (Table 2) . Computed tomography of the chest revealed multiple enlarged mediastinal lymph nodes in case 3. Video-assisted thoracoscopic (VATS) biopsy of the mediastinal lymph nodes and histological analysis of the specimens provided a diagnosis of the hyaline vascular type of Castleman's disease. In addition to multiple mediastinal and hilar lymphadenopathy, cases 4 and 5 were found by high-resolution CT to exhibit thickening of the peribronchovascular interstitium and interlobular septa as well as poorly defined glass-like opacities present in the centrilobular gland in a perilymphatic distribution ( Fig. 2A and B) . These two patients also had an in- showed no radionuclide accumulation in any region including the affected lymph nodes and lungs (Fig. 2D ).
Discussion
Castleman's disease was first described as a pathological entity in 1954 and was later defined by Castleman et al in
(1 1). Diagnosis of Castleman's disease is problematic
given that histological analysis is usually required.
Clinically, Castleman's disease must be distinguished from reactive lymph node hyperplasia and malignant lymph node hyperplasia, and especially from malignant lymphoma, which is sometimes associated with this disease (12) .
Although 67Ga scintigraphy is often used to evaluate patients with lymphoproliferative disorders ( 10), few studies have de- Wehave now shown that two patients (cases 4 and 5) diagnosed with multicentric Castleman' s disease of the plasma cell type, a clinical entity with potential for malignant transformation, did not exhibit 67Ga uptake. These results are consistent with those of a recent study demonstrating the absence of 67Gauptake in three cases of this type of Castleman's disease (13) . Wealso failed to detect 67Ga uptake in a rare case (case 2) of unicentric Castleman's disease of the plasma cell type. Together, these observations suggest that the plasma cell type of Castleman's disease is not detectable by 67Ga scintigraphy.
Internal Medicine Vol. 42, No. 8 (August 2003) Figure 2 . Multicentric Castleman's disease of the plasma cell type in a 53-year-old woman.A, Contrast-enhanced chest CTimage (mediastinal window), showing enlarged mediastinal and hilar lymph nodes. B, Chest high-resolution computed tomography (HRCT)reveals thickening of the peribronchovascular interstitium, interlobular septa, and poorly defined centrilobular ground glass opacities that were perilymphatic in distribution. C, Hematoxylin-eosin staining of a specimen of the resected mass, revealing marked interfollicular infiltration by plasma cells (original x400). D, "Ga scintigraphy was performed as described in Fig. 1 . Planar images on day 3 after "Ga injection demonstrate no "Ga uptake.
)7Ga Uptake in Castleman's Disease
The hyaline vascular type of Castleman's disease, the more common of the two histopathologic types, is usually apparent in the thorax, although it can manifest at any site where lymph nodes are normally present (1-3). In the present study, 67Ga scintigraphy yielded negative results for the two patients (cases 1 and 3) with the hyaline vascular type of Castleman's disease in the mediastinum. A review of studies published in English from 1966 onward revealed one report that failed to detect 67Ga uptake in a patient with the hyaline vascular type of Castleman's disease and two reports each detecting 67Ga uptake in one such patient (14) (15) (16) . One of the two previous 67Gauptake-positive patients showed unusual histological features with a predominance of the hyaline vascular type of disease (16) . Given the small sample size, it is not possible to explain the variance in 67Ga uptake in these patients. The positive 67Ga uptake previously observed in such patients mayhave resulted from chronic infection including mycobacteriosis. Further studies with larger numbers of patients are required to resolve this issue.
In the present study, none of the five cases of Castleman's disease manifested 67Ga uptake. Our results suggest that 67Ga uptake does not occur in either type of this disease. The mechanisms regulating 67Ga uptake by tumor cells have been found to be partially dependent on the expression of the transferrin receptor (CD71) in these cells (10, 17) . Transferrin receptor is also expressed in activated or proliferating lymphocytes and thus is more frequently expressed in high grade than in low grade lymphomas. A low density of activated lymphocytes at the involved sites mayresult in the ab- scintigraphy may help to narrow the diagnostic possibilities. With regard to the association between malignant lymphoma and Castleman's disease, non-Hodgkin's lymphoma is the most often associated with the multicentric presentation and Hodgkin's disease with the unicentric presentation (12) . In a previous study of human immunodeficiency virus-positive patients with lymphadenopathy, those individuals that manifested 67Ga uptake in lymph nodes were found to have tuberculosis or lymphoma, whereas those who did not exhibit 67Ga uptake had reactive follicular hyperplasia, suggesting a specificity of 67Ga uptake for lymphoma (18) . Together, these observations suggest that 67Gascintigraphy, as a noninvasive tool, might be of value in the early detection of malignant lymphomas that develop during the course of Castleman's disease.
